Age-Stratified Seroprevalence of Cytomegalovirus and Epstein–Barr Virus in a Population-Based Cohort in Japan, 2017–2024

Clicks: 5
ID: 338695
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #319 of 326 articles by views in Open forum infectious diseases

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 326 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Abstract Background Cytomegalovirus (CMV) and Epstein–Barr virus (EBV) are ubiquitous latent herpes viruses, but contemporary population-based seroprevalence data in Japan remain limited, particularly in younger age groups. This study aimed to characterize age- and sex-specific CMV and EBV seroprevalence in a population-based Japanese cohort and to describe combined serostatus patterns across age groups. Methods We conducted a cross-sectional seroepidemiological analysis of the Tohoku Medical Megabank Project Birth and Three-Generation (TMM BirThree) cohort. Serum samples collected between 2017 and 2024 were tested for CMV IgG (age 4–40 years; n = 2,247) and EBV viral capsid antigen IgG (age 4–30 years; n = 1,647) using commercial ELISA. Seroprevalence was stratified by age and sex. Combined CMV/EBV serostatus patterns were described, and sensitivity analyses assessed temporal consistency and intra-family clustering. Results CMV seroprevalence increased during childhood and adolescence and plateaued at approximately 70–80% in early adulthood, whereas EBV seroprevalence rose steadily, exceeding 70% in late adolescence and 90% in the late 20s, with minimal sex differences. Dual seropositivity increased with age, the CMV−/EBV− group declined, and CMV−/EBV+ remained more common than CMV+/EBV− across all age groups. These patterns were consistent in sensitivity analyses. Conclusions CMV and EBV exhibit distinct age-related seroepidemiologic patterns in Japan despite overlapping transmission routes. The early plateau of CMV seroprevalence and near-universal EBV seropositivity by young adulthood indicate divergent infection dynamics with implications for congenital CMV prevention, infectious mononucleosis risk, and ongoing vaccine strategy.
Reference Key
openalex_W7225263482 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors
Journal Open forum infectious diseases
Year 2026
DOI
10.1093/ofid/ofag678
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.